Sumner Michael John 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Award
Common Stock Option
2025-02-27+42,900→ 42,900 totalExercise: $1.94From: 2025-02-27Exp: 2035-02-27→ Common Stock (42,900 underlying) - Exercise/Conversion
Common Stock
2025-02-26+5,010→ 13,229 total - Exercise/Conversion
Restricted Stock Unit
2025-02-26−5,010→ 10,019 total→ Common Stock (5,010 underlying) - Award
Restricted Stock Unit
2025-02-27+34,650→ 34,650 total→ Common Stock (34,650 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]The vesting schedule for the 42,900 options is as follows: 21,450 shares vested on February 27, 2025 and 21,450 shares will vest on February 26, 2026.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 is as follows: 11,550 shares will vest on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.